[ad_1] Last quarter, Pfizer chief Ian Read was optimistic about the Trump administration's plan to lower drug prices, even after Trump's tweet led his company to postpone price increases. planned prices.
Read More »GW Pharma's action jumps to record after DEA's stance on its CBD drug, delays in the cannabis sector
[ad_1] Shares of GW Pharmaceuticals PLC hit a record high on Thursday after the medical marijuana company announced a new position of the Drug Enforcement Administration on its approved drug containing cannabidiol …
Read More »